Is there a paraneoplastic ALS?

References

• Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet Journal of Rare Diseases. 2009;4:3 doi:10.1186/1750-1172-4-3.
   PubMed Web of Science ®Google Scholar
• Fang F, Al-Chalabi A, Ronnevi L, Turner M, Wirdefeldt K, Kamel F, et al. Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:362–8.
   PubMed Web of Science ®Google Scholar
• Freedman D, Curtis R, Daughertt S, Goedert J, Kuncl R, Tucker M. The association between cancer and amyotrophic lateral sclerosis. Cancer Causes Control. 2013;24:55–60.
   PubMed Web of Science ®Google Scholar
• Freedman D, Wu J, Daugherty S, Kuncl R, Enewold E, Pfeiffer R. The risk of amyotrophic lateral sclerosis after cancer in US ederly adults: a population based prospective study. Int J Cancer. 2014;135:1745–50.
   PubMed Web of Science ®Google Scholar
• Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349: 1543–54.
   PubMed Web of Science ®Google Scholar
• Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G, et al. Paraneoplastic neurologic syndrome in the PNS. Euronetwork Database. Arch Neurol. 2010; 67:330–5.
   PubMedGoogle Scholar
• Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135–40.
   PubMed Web of Science ®Google Scholar
• Lee J, Macht S, Albrecht P, Hartung HP, Goebels N. Brachial amyotrophic diparesis associated with anti-Hu-positive anterior horn cell disease and autonomic disorder. J Neurol. 2013;260:301–2.
   PubMed Web of Science ®Google Scholar
• Verma A, Berger J, Snodgrass S, Petito C. Motor neuron disease: a paraneoplastic process with anti-Hu antibody and small-cell lung carcinoma. Ann Neurol. 1996;40:112–6.
   PubMed Web of Science ®Google Scholar
• Forsyth PA, Dalmau J, Graus F, Cwik V, Rosenblum MK, Posner JB. Motor neuron syndromes in cancer patients. Ann Neurol. 1997;41:722–30.
   PubMed Web of Science ®Google Scholar
• Younger D, Graber J, Hayakawa-Yano Y, Parveen S, Frank M, Darnell R. RI/NOVA gene-associated paraneoplastic subacute motor neuronopathy. Muscle Nerve. 2013; 47:617–8.
   PubMed Web of Science ®Google Scholar
• Khwaja S, Sripathi N, Ahmad KK, Lennon V. Paraneoplastic motor neuron disease with type 1 Purkinje cell antibodies. Muscle Nerve. 1998;21:943–5.
   PubMed Web of Science ®Google Scholar
• Garcia Martin G, Perez Errazquin F, Chamoro Munoz M, Romero Acebal M. Amyotrophic lateral sclerosis and anti-CV2 antibodies. Paraneoplastic association? Neurologia. 2007;22:406–9.
   Google Scholar
• Ferracci F, Fassetta G, Butler M, Floyd S, Solimena M, de Camilli P. A novel anti-neuronal antibody in a motor neuron syndrome associated with breast cancer. Neurology. 1999;53:852–5.
   PubMed Web of Science ®Google Scholar
• Berghs S, Ferracci F, Maksimova E, Gleason S, Leszczynsk N, Butler M, et al. Autoimmunity to βIV spectrin in paraneoplastic lower motor neuron syndrome. Proc Natl Acad Sci. 2001;98:6945–50.
   PubMed Web of Science ®Google Scholar
• Stich O, Kleer B, Rauer S. Absence of paraneoplastic anti-neuronal antibodies in sera of 145 patients with motor neuron disease. J Neurol Neurosurg Psychiatry. 2007;78: 883–5.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Rowland LP, Younger DS, Sherman WH, Hays AP, Louis ED, et al. Lymphoproliferative disorders and motor neuron disease: an update. Neurology. 1997; 48:1671–8.
   PubMed Web of Science ®Google Scholar
• Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology. 2011;76:705–10.
   PubMed Web of Science ®Google Scholar
• Flanagan E, Sandroni P, Pittock S, Inwards D, Jones L. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve. 2012;46:823–7.
   PubMed Web of Science ®Google Scholar
• Schold SC, Cho ES, Somasundaram M, Posner JB. Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol. 1979;5:271–87.
   PubMed Web of Science ®Google Scholar
• Corcia P, Honnorat J, Guennoc AM, de Toffol B, Autret A. Sclérose latérale primitive et cancer du sein: syndrome neurologique paranéoplasique ou association fortuite ? Rev Neurol. 2000;156:1020–2.
   PubMed Web of Science ®Google Scholar
• Sadot E, Carluer L, Corcia P, Delozier Y, Levy C, Viader F. Breast cancer and motor neuron disease: clinical study of seven cases. Amyotroph Lateral Scler. 2007;5:288–91.
   Google Scholar
• Mitchell DM, Olczak SA. Remission of a syndrome indistinguishable from motor neuron disease after resection of bronchial carcinoma. Br Med J. 1979;2:176–7.
   PubMed Web of Science ®Google Scholar
• Evans B, Fagan C, Arnold T, Dropcho E, Oh S. Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy. Neurology. 1990;40:960–2.
   PubMed Web of Science ®Google Scholar
• Turk HM, Ozet A, Kuzhan O, Komurcu F, Arpaci F, Ozturk B, et al. Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma. Med Princ Pract. 2009;18:73–5.
   PubMed Web of Science ®Google Scholar
• Coban A, Ulusoy C, Giris M, Turan S, Turkoglu R, Tuzun E, et al. Serum anti-neuronal antibodies in amyotrophic lateral sclerosis. Int J Neurosci. 2013;123:557–62.
   PubMed Web of Science ®Google Scholar
• Younes-Mhenni S, Janier MF, Cinotti L, Antoine JC, Tronc F, Cottin V, et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain. 2004;127:2331–8.
   PubMed Web of Science ®Google Scholar
• Antoine JC, Camdessanché JP. Paraneoplastic syndromes of the peripheral nervous system. Press Med. 2013;42:235–44.
   PubMed Web of Science ®Google Scholar
• Antoine JC, Camdessanché JP. Treatment options in paraneoplastic syndromes of the peripheral nervous system. Curr Treat Opinions Neurol. 2013;15:210–23.
   PubMed Web of Science ®Google Scholar
• Drlicek M, Bianch G, Bogliun G, Casati B, Grisold W, Kolig C, et al. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. J Neurol. 1997;244:85–9.
   PubMed Web of Science ®Google Scholar